Global Head of Evidence Generation & HTA Strategy

Takeda Pharmaceutical Co.; Zürich; Teletrabalho; CHF 273 000 - 376 000; Tempo integral

Resumo da oferta

Takeda Pharmaceutical Co. seeks a Head of HTA, COA, and PED in Global Evidence Generation. You will lead a team delivering fit-for-purpose COA endpoints, PED strategies, and high-quality evidence to support HTA and payer differentiation worldwide.

Collaboration with internal and external stakeholders is essential to shape methods and guidelines for evolving global health authorities. The role emphasizes strategic decision-making, training raters, and advancing evidence generation to support

Qualificações

• Fifteen or more years of experience in evidence generation, HTA, COA, PED, or related field.
• Advanced degree in a scientific, clinical, epidemiologic, quantitative, or health outcomes discipline.

Responsabilidades

• Lead a team of experts for COA endpoint development, validation, execution, and quality control across regulatory, payer, physician, and patient needs.
• Drive generation and communication of high-quality, fit-for-purpose evidence for HTA and payer evaluations globally.

Conhecimentos

15+ years exp

HTA knowledge

Team leadership

Global experience

Stakeholder engagement

Rater training knowledge

Policy environment understanding

Formação académica

Advanced degree in science/health outcomes

Descrição da oferta de emprego

Takeda Pharmaceutical Co. seeks a Head of HTA, COA, and PED in Global Evidence Generation. You will lead a team delivering fit-for-purpose COA endpoints, PED strategies, and high-quality evidence to support HTA and payer differentiation worldwide.

Collaboration with internal and external stakeholders is essential to shape methods and guidelines for evolving global health authorities. The role emphasizes strategic decision-making, training raters, and advancing evidence generation to support